Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cerebrospinal Fluid Restores Vision

01.11.2004


A new method for visual impairment treatment has been discovered by researchers of the Institute of Human Brain, Russian Academy of Sciences. The patients suffering from visual impairment can be helped if a healthy donor’s cerebrospinal fluid is introduced to the parent’s vertebral canal – this method is called liquortransfusion. Physiologists have determined that the method is effective even when prescription of visual impairment exceeds five years. Eyesight improves with 83 percent of patients.



The reasons that deprive people of the ability for normal vision are multifarious – these are not only eye diseases, but also lesions of optic nerve, visual tracts and visual centers in the cerebrum. Till recently, physicians believed that effective treatment of visual system was possible only at early stages when no more than three months elapsed since the onset. Treatment at later stages was normally unsuccessful. Now physicians have the opportunity to restore vision of the patients who suffered visual impairment five and more years ago.

The method of endolumbal introduction (into the vertebral canal) of a healthy donor’s cerebrospinal fluid has been applied for several years already by specialists of the Institute of Human Brain, Russian Academy of Sciences. They have taken out a patent of the Russian Federation for application of this method for treatment of heavy neurologic patients who lost the ability for normal seeing. The donors are healthy volunteers, usually relatives of the patients. The cerebrospinal fluid (liquor) is transfused either immediately after it is taken from the donor or after short-term conservation and sterilization. Likewise blood transfusion, the group should be taken into account – the researchers have discovered four groups of cerebrospinal fluid (liquor) similar to four groups of blood.


Specialists state that one transfusion is sufficient to improve vision, in some cases the transfusion is repeated in several months. Vision is effectively restored with 83 percent of patients within the first two years after the disease onset, and at later stages - in 67.5 percent of cases. The researchers emphasize that treatment effectiveness does not significantly depend on the cause of the disease. The majority of patients experience vision improvement within the first two weeks after the procedure. Later on, vision rate continues to improve. Regardless of the visual system lesions degree, the general treatment response consists in expanding the field of vision. Even in case of amaurosis or if only light sensitivity is retained, it is possible to restore the outline vision and even subject vision after the cerebrospinal fluid (liquor) has been transfused.

The researchers explain the medicinaleffect of the donor cerebrospinal fluid by the presence of the substances similar to drugs in it – i.e., neuropeptides, which impact positively the systems of neural and neurohumoral regulation of the patient’s brain. These substances cause plastic rearrangements in the unaffected parts of the brain, and change interaction of various celebral structures that ensure visual functions. That allows the brain to make up the existing defects.

Clinical observations have proved that the cerebrospinal fluid (liquor) transfusion promotes electric cerebral biocurrents and initiates reorganization processes in the visual zone of the cerebral cortex and in the central nervous system as a whole. Neurohumoral regulation is evident in the fact that previously formed pathological relationship between cerebral portions gets suppressed and new relationship originates, which enables the visual system to function normally.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>